Point72 Asset Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.37M | Buy |
+470,000
| New | +$8.37M | 0.02% | 614 |
|
|
2024
Q2 | – | Sell |
-32,600
| Closed | -$510K | – | 1614 |
|
|
2024
Q1 | $510K | Sell |
32,600
-335,800
| -91% | -$5.25M | ﹤0.01% | 1021 |
|
|
2023
Q4 | $5.5M | Buy |
368,400
+356,856
| +3,091% | +$5.33M | 0.01% | 703 |
|
|
2023
Q3 | $186K | Sell |
11,544
-13,289
| -54% | -$215K | ﹤0.01% | 1155 |
|
|
2023
Q2 | $1.03M | Buy |
+24,833
| New | +$1.03M | ﹤0.01% | 852 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 1903 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 1330 |
|
|
2019
Q3 | – | Sell |
-8,126
| Closed | -$514K | – | 1282 |
|
|
2019
Q2 | $514K | Sell |
8,126
-437
| -5% | -$27.6K | ﹤0.01% | 745 |
|
|
2019
Q1 | $412K | Buy |
+8,563
| New | +$412K | ﹤0.01% | 785 |
|